Tecnoglass Inc. Debt Disclosure
Note 14. Debt
The Company’s debt is comprised of the following:
December 31, 2025 | December 31, 2024 | |||||||
| Revolving lines of credit | $ | 387 | $ | 600 | ||||
| Finance lease | 41 | 111 | ||||||
| Other current debt | 378 | |||||||
| Senior Secured Credit Facility | 174,000 | 110,000 | ||||||
| Less: Deferred cost of financing | (2,799 | ) | (1,782 | ) | ||||
| Total obligations under borrowing arrangements | 171,629 | 109,307 | ||||||
| Less: Current portion of long-term debt and other current borrowings | 427 | 1,087 | ||||||
| Long-term debt | $ | 171,202 | $ | 108,220 | ||||
In September 2025, the Company entered into a new Senior Secured Credit Facility , transitioning from a term loan and revolving facility structure to a fully committed revolving facility structure which allowed the company (i) increase total committed borrowing capacity from $150 million to $500 million, (ii) reduce borrowing costs by approximately 25 basis points, and (iii) extend the initial maturity date by five years to December 2030. Borrowings under the new facility bear interest at the Secured Overnight Financing Rate (SOFR) with no floor, plus a spread of 1.25 % based on the Company’s net leverage ratio (previously 1.50 % over SOFR). The effective interest rate for the facility, including deferred issuance costs, is 6.98 % as of December 31, 2025. The Company incurred total costs and fees of $2,783 in lender fees which were capitalized as deferred financing costs, and are presented as a deduction from the related debt liability.
The transaction was accounted for as a debt extinguishment under ASC 470-50. Accordingly, the prior term-loan and revolving credit facilities were derecognized, and the new revolving facility was initially recognized at its principal amount, net of deferred financing costs. As a result, the Company recognized a loss on extinguishment of debt of $1,354, representing $1,302 for the write-off of the remaining unamortized deferred financing costs related to the prior term-loan and revolving credit facilities, and $52 of termination costs associated with closing the prior facility. Cash proceeds from the new facility and repayments of the extinguished debt are reflected within financing activities in the condensed consolidated statements of cash flows. Of the $2,783 of total fees incurred, $1,803 were deducted from the gross proceeds and presented net within “Proceeds from debt,” with the remaining $980 recorded as cash outflows classified under “Deferred financing costs and debt issuance fees” within financing activities. During Q4 2025, the company drew down $60 million from its revolving credit facility.
Maturities of long-term debt and other current borrowings as of December 31, 2025, are as follows:
| 2026 | 427 | |||
| 2027 | ||||
| 2028 | ||||
| 2029 | ||||
| 2030 | 174,000 | |||
| Total | $ | 174,427 |
The Company’s loans have maturities ranging from a few weeks to 3 years. Our credit facilities bear interest at a weighted average of 5.15% as of December 31, 2025.
Interest expense and deferred financing cost is comprised of the following:
| Years ended December 31, | ||||||||||||
| 2025 | 2024 | 2023 | ||||||||||
| Interest expense | $ | 5,965 | $ | 6,219 | $ | 7,935 | ||||||
| Deferred financing cost | 935 | 1,214 | 1,243 | |||||||||
| Derivative financial instrument gain | (3,455 | ) | ||||||||||
| Interest expense and deferred financing cost | $ | 3,445 | $ | 7,433 | $ | 9,178 | ||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 2, 2026 | Showing above |
| 2024 | Feb 28, 2025 | |
| 2023 | Feb 29, 2024 | |
| 2022 | Mar 7, 2023 | |
| 2021 | Mar 16, 2022 | |
| 2020 | Mar 8, 2021 | |
| 2019 | Mar 6, 2020 | |
| 2018 | Mar 8, 2019 | |
| 2017 | Mar 14, 2018 | |
| 2016 | Mar 10, 2017 | |
| 2015 | May 31, 2016 | |
About Debt Disclosures
Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.
Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.